M Steven Oberste Selected Research

acute flaccid myelitis

6/2022	Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
1/2022	Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
1/2020	Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.
1/2019	Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
1/2018	Diagnostic Assay Development for Poliovirus Eradication.
1/2016	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Steven Oberste Research Topics

Disease

54	Poliomyelitis (Polio) 06/2022 - 04/2002
15	Infections 01/2020 - 03/2008
6	acute flaccid myelitis 06/2022 - 01/2016
3	Malnutrition (Nutritional Deficiencies) 01/2018 - 01/2014
3	Asthma (Bronchial Asthma) 11/2016 - 09/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 03/2013
2	Meningitis 01/2020 - 02/2011
2	Seizures (Absence Seizure) 01/2020 - 05/2018
2	Diarrhea 08/2017 - 01/2014
2	Human Influenza (Influenza) 11/2016 - 03/2013
2	Virus Diseases (Viral Diseases) 09/2015 - 03/2011
2	Enterovirus Infections 08/2015 - 11/2013
2	Exanthema (Rash) 07/2015 - 03/2013
2	Myocarditis (Carditis) 09/2009 - 09/2007
1	Hypersensitivity (Allergy) 01/2021
1	Gastroenteritis 11/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 05/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Growth Disorders 09/2017
1	Shock 11/2016
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2016
1	Vaccine-Preventable Diseases 01/2016
1	Intussusception 11/2015
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 07/2015
1	Chickenpox 07/2015
1	Sepsis (Septicemia) 01/2015
1	Inflammation (Inflammations) 08/2014
1	Mumps 12/2013
1	Dengue (Dengue Fever) 03/2013
1	Hemorrhage 03/2013
1	Malaria 01/2012
1	Chest Pain (Chest Pains) 01/2012
1	Cough 01/2012
1	Paralysis (Palsy) 01/2011
1	Left Ventricular Dysfunction 09/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009
1	Neonatal Sepsis 03/2008

Drug/Important Bio-Agent (IBA)

44	VaccinesIBA 06/2022 - 04/2002
11	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2022 - 11/2013
11	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2021 - 04/2013
10	AntibodiesIBA 11/2019 - 01/2014
7	Neutralizing AntibodiesIBA 01/2021 - 01/2011
7	Antiviral Agents (Antivirals)IBA 01/2020 - 03/2008
6	Poliovirus VaccinesIBA 01/2021 - 01/2016
4	Immunoglobulin A (IgA)IBA 01/2018 - 01/2014
3	RNA (Ribonucleic Acid)IBA 11/2019 - 03/2008
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2015 - 02/2011
3	EnzymesIBA 01/2014 - 03/2008
3	Nucleic AcidsIBA 02/2011 - 09/2008
2	Biological ProductsIBA 01/2020 - 11/2013
2	Peptides (Polypeptides)IBA 11/2019 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2018 - 08/2015
2	AntigensIBA 01/2018 - 01/2012
2	pocapavirIBA 02/2017 - 01/2015
2	Immunoglobulin M (IgM)IBA 01/2016 - 12/2013
1	Fibroins (Fibroin)IBA 11/2020
1	Rotavirus VaccinesIBA 11/2019
1	Disinfectants (Biocides)IBA 12/2018
1	Acyclovir (Aciclovir)FDA LinkGeneric 05/2018
1	Albuterol (Salbutamol)FDA LinkGeneric 11/2016
1	SteroidsIBA 11/2016
1	varicella-zoster immune globulin (VZIG)IBA 07/2015
1	CytokinesIBA 08/2014
1	Glucagon (Glukagon)FDA Link 08/2014
1	Insulin (Novolin)FDA Link 08/2014
1	SuspensionsIBA 05/2014
1	Capsid Proteins (Capsid Protein)IBA 05/2014
1	ImmunosorbentsIBA 01/2014
1	LipidsIBA 11/2011
1	Polysaccharides (Glycans)IBA 11/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2011
1	Interferon Type IIBA 03/2011
1	Pattern Recognition ReceptorsIBA 03/2011
1	Immune Sera (Antisera)IBA 01/2011
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2008
1	LectinsIBA 03/2008
1	ParaffinIBA 09/2007

Therapy/Procedure

3	Therapeutics 09/2015 - 01/2015
1	Intradermal Injections 01/2019
1	Ambulatory Care (Outpatient Care) 08/2017
1	Length of Stay 11/2016
1	Mechanical Ventilators (Ventilator) 11/2015
1	Critical Care (Surgical Intensive Care) 11/2015
1	Respiratory Therapy (Therapy, Respiratory) 09/2015
1	Tourniquets 03/2013
1	Heart Transplantation (Grafting, Heart) 09/2009